Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC-Reference-Cited by-同舟云学术

Clinical Utility of Cerebrospinal Fluid Cell-Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK-Rearranged NSCLC

Published:2019-05 Issue:5 Volume:14 Page:924-932
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Zheng Mei-Mei,Li Yang-Si,Jiang Ben-Yuan,Tu Hai-Yan,Tang Wen-Fang,Yang Jin-Ji,Zhang Xu-Chao,Ye Jun-Yi,Yan Hong-Hong,Su Jian,Zhou Qing,Zhong Wen-Zhao,Yang Xue-Ning,Guo Wei-Bang,Chuai Shannon,Zhang Zhou,Chen Hua-Jun,Wang Zhen,Liu Chao,Wu Yi-Long

Funder

National Key R&D Program of China

National Health and Family Control Committee

Guangdong Science and Technology Department

Guangzhou Science and Technology Bureau

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference18 articles.

1. Leptomeningeal carcinomatosis in non-small cell lung cancer patients: a continuing challenge in the personalized treatment era;Remon;Cancer Treat Rev,2017

2. Leptomeningeal metastases in patients with NSCLC with EGFR mutations;Li;J Thorac Oncol,2016

3. Leptomeningeal metastases of solid cancer;Le Rhun;Curr Opin Neurol,2016

4. Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC patients treated with first-line intercalated erlotinib and chemotherapy;Mok;Clin Cancer Res,2015

5. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA;Murtaza;Nature,2013

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the Role of Liquid Biopsy in Non-small Cell Lung Cancer (NSCLC);Clinical Oncology;2024-10

2. Combination of Cytologic Findings and Circulating Tumor DNA From Cerebrospinal Fluid Revealed SCLC Transformation in Patients With Leptomeningeal Metastases of Lung Adenocarcinoma;JTO Clinical and Research Reports;2024-09

3. Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC;Cell Reports;2024-08

4. Complete and durable regression of leptomeningeal involvement during lorlatinib treatment in a patient with lung cancer;Anti-Cancer Drugs;2024-07-09

5. Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis;npj Precision Oncology;2024-05-28